Literature DB >> 28860189

The major histocompatibility complex class I immunopeptidome of extracellular vesicles.

Silvia A Synowsky1, Sally L Shirran1, Fiona G M Cooke2, Antony N Antoniou3, Catherine H Botting1, Simon J Powis4.   

Abstract

Extracellular vesicles (EVs) are released by most cell types and have been associated with multiple immunomodulatory functions. MHC class I molecules have crucial roles in antigen presentation and in eliciting immune responses and are known to be incorporated into EVs. However, the MHC class I immunopeptidome of EVs has not been established. Here, using a small-scale immunoisolation of the antigen serotypes HLA-A*02:01 and HLA-B*27:05 expressed on the Epstein-Barr virus-transformed B cell line Jesthom and MS of the eluted peptides from both cells and EVs, we identified 516 peptides that bind either HLA-A*02:01 or HLA-B*27:05. Of importance, the predicted serotype-binding affinities and peptide-anchor motifs did not significantly differ between the peptide pools isolated from cells or EVs, indicating that during EV biogenesis, no obvious editing of the MHC class I immunopeptidome occurs. These results, for the first time, establish EVs as a source of MHC class I peptides that can be used for the study of the immunopeptidome and in the discovery of potential neoantigens for immunotherapies.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  extracellular vesicles; immunology; major histocompatibility complex (MHC); mass spectrometry (MS); proteomics

Mesh:

Substances:

Year:  2017        PMID: 28860189      PMCID: PMC5641862          DOI: 10.1074/jbc.M117.805895

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Follicular dendritic cells carry MHC class II-expressing microvesicles at their surface.

Authors:  K Denzer; M van Eijk; M J Kleijmeer; E Jakobson; C de Groot; H J Geuze
Journal:  J Immunol       Date:  2000-08-01       Impact factor: 5.422

Review 2.  Exosomes: composition, biogenesis and function.

Authors:  Clotilde Théry; Laurence Zitvogel; Sebastian Amigorena
Journal:  Nat Rev Immunol       Date:  2002-08       Impact factor: 53.106

3.  Nanoparticle tracking analysis monitors microvesicle and exosome secretion from immune cells.

Authors:  Chin Y Soo; Yaqiong Song; Ying Zheng; Elaine C Campbell; Andrew C Riches; Frank Gunn-Moore; Simon J Powis
Journal:  Immunology       Date:  2012-06       Impact factor: 7.397

4.  NetMHCcons: a consensus method for the major histocompatibility complex class I predictions.

Authors:  Edita Karosiene; Claus Lundegaard; Ole Lund; Morten Nielsen
Journal:  Immunogenetics       Date:  2011-10-20       Impact factor: 2.846

5.  Nanoparticle analysis of circulating cell-derived vesicles in ovarian cancer patients.

Authors:  Cicek Gercel-Taylor; Safinur Atay; Richard H Tullis; Mehmet Kesimer; Douglas D Taylor
Journal:  Anal Biochem       Date:  2012-06-09       Impact factor: 3.365

6.  Novel MHC class I structures on exosomes.

Authors:  Sarah Lynch; Susana G Santos; Elaine C Campbell; Ailish M S Nimmo; Catherine Botting; Alan Prescott; Antony N Antoniou; Simon J Powis
Journal:  J Immunol       Date:  2009-07-13       Impact factor: 5.422

7.  Direct exosome stimulation of peripheral human T cells detected by ELISPOT.

Authors:  Charlotte Admyre; Sara M Johansson; Staffan Paulie; Susanne Gabrielsson
Journal:  Eur J Immunol       Date:  2006-07       Impact factor: 5.532

8.  Preparation of human ovarian cancer ascites-derived exosomes for a clinical trial.

Authors:  H Navabi; D Croston; J Hobot; A Clayton; L Zitvogel; B Jasani; R Bailey-Wood; K Wilson; Z Tabi; M D Mason; M Adams
Journal:  Blood Cells Mol Dis       Date:  2005 Sep-Oct       Impact factor: 3.039

9.  Seq2Logo: a method for construction and visualization of amino acid binding motifs and sequence profiles including sequence weighting, pseudo counts and two-sided representation of amino acid enrichment and depletion.

Authors:  Martin Christen Frølund Thomsen; Morten Nielsen
Journal:  Nucleic Acids Res       Date:  2012-05-25       Impact factor: 16.971

10.  The MHC class I peptide repertoire is molded by the transcriptome.

Authors:  Marie-Hélène Fortier; Etienne Caron; Marie-Pierre Hardy; Grégory Voisin; Sébastien Lemieux; Claude Perreault; Pierre Thibault
Journal:  J Exp Med       Date:  2008-02-25       Impact factor: 14.307

View more
  7 in total

Review 1.  Brain Theranostics and Radiotheranostics: Exosomes and Graphenes In Vivo as Novel Brain Theranostics.

Authors:  Minseok Suh; Dong Soo Lee
Journal:  Nucl Med Mol Imaging       Date:  2018-11-09

Review 2.  Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometry.

Authors:  Lena Katharina Freudenmann; Ana Marcu; Stefan Stevanović
Journal:  Immunology       Date:  2018-05-08       Impact factor: 7.397

3.  Characterization of protein complexes in extracellular vesicles by intact extracellular vesicle crosslinking mass spectrometry (iEVXL).

Authors:  Julia Bauzá-Martinez; Gad Armony; Matti F Pronker; Wei Wu
Journal:  J Extracell Vesicles       Date:  2022-07

4.  HLA-B and cysteinylated ligands distinguish the antigen presentation landscape of extracellular vesicles.

Authors:  Julia Bauzá-Martinez; Albert J R Heck; Wei Wu
Journal:  Commun Biol       Date:  2021-07-01

5.  Detection of HIV-1 and Human Proteins in Urinary Extracellular Vesicles from HIV+ Patients.

Authors:  Samuel I Anyanwu; Akins Doherty; Michael D Powell; Chamberlain Obialo; Ming B Huang; Alexander Quarshie; Claudette Mitchell; Khalid Bashir; Gale W Newman
Journal:  Adv Virol       Date:  2018-03-12

Review 6.  The transformative impact of extracellular vesicles on developing sperm.

Authors:  Michael P Rimmer; Christopher D Gregory; Rod T Mitchell
Journal:  Reprod Fertil       Date:  2021-06-25

Review 7.  What Is the Role of HLA-I on Cancer Derived Extracellular Vesicles? Defining the Challenges in Characterisation and Potential Uses of This Ligandome.

Authors:  Caitlin Boyne; Debra Lennox; Olivia Beech; Simon J Powis; Pankaj Kumar
Journal:  Int J Mol Sci       Date:  2021-12-17       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.